510(k) Report

FDA applicant

Xtreem Pulse, LLC

New York, NY6 decisions2018–20260 recalls

FDA records 6 decisions for Xtreem Pulse, LLC (New York, NY) from 2018 to 2026: 6 510(k) clearances. Most are in product codes NFO (Stimulator, Transcutaneous Electrical…) and DRN (Device, Counter-Pulsating, External). Since 2016 its 510(k)s took a median of 112 days from receipt to decision, against 139 for FDA’s reviews in the same codes and years. Its devices cite 9 predicates, 4 of them its own earlier devices. No recall is linked to its devices.

FDA’s records also spell it “Xtreem Pulse”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided Xtreem Pulse, LLC’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2018: 12019: 12022: 12023: 12025: 12026 (partial year): 1
2018high 1 (2018) · low 0 (2020)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2018.

FIG. 1 — Xtreem Pulse, LLC by year, 2018–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Xtreem Pulse, LLC’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report